Emami Q4 FY26: Core portfolio holds up as summer demand and West Asia disruption weigh on results

Emami Limited closed Q4 FY26 with a mixed scorecard. The quarter was shaped by two clear external shocks: a disrupted summer season that hit the cooling and prickly heat portfolio, and geopolitical disruption in West Asia that affected international shipments and freight costs. Against that backdrop, the underlying domestic business outside summer-linked categories stayed firm.

On a consolidated basis, revenue from operations fell 4 percent year on year to 925.1 crore in Q4 FY26. EBITDA declined 15 percent to 186.7 crore, and profit after tax fell 12 percent to 143.2 crore. Management framed these pressures as temporary rather than structural and said momentum should improve from the next quarter.

The quarter still offered signals of execution strength. Gross margin expanded to 68.4 percent, up 250 basis points, helped by calibrated pricing, operating efficiency, and a lower materials cost ratio. At the same time, Emami increased advertising and promotion spending by 12 percent, taking A and P to 22.9 percent of revenue. That choice made EBITDA margins compress, but it also indicates the company did not retreat from brand investment despite near-term disruption.

What moved the quarter: domestic ex-summer strength, summer weakness, and a late hit in international

Emami’s domestic business was split into two very different realities. Domestic net sales excluding the summer portfolio grew 11 percent in Q4 FY26 with volume growth of 7 percent. This performance helped validate the company’s claim that the softness was not broad-based. In contrast, the summer portfolio declined 22 percent, pulling total domestic net sales down 3 percent and volumes down 7 percent.

Within domestic brands, growth was strongest in categories that are less weather-dependent. The pain management range grew 11 percent in Q4 FY26, and the healthcare range grew 7 percent. Kesh King grew 14 percent in the quarter, while 7 Oils in One rose 34 percent and The Man Company and Brillare together grew 34 percent. The cooling-led portfolio was the clear drag: Navratna and Dermicool range declined 21 percent, and BoroPlus range declined 8 percent.

International performance also swung sharply within the quarter. The company reported that international business in January and February 2026 grew 16 percent, but the full quarter ended down 5 percent due to the West Asia conflict. The disruption affected shipping routes through the Strait of Hormuz, increased freight costs, and impacted supply chains. International revenues contributed 19 percent of overall sales in Q4 FY26.

This split matters for investors because it helps separate cyclicality from competitiveness. When most of the portfolio grows at healthy rates and the weakness is concentrated in season-linked categories and logistics-driven geographies, it becomes easier to treat the quarter as a volatility event rather than an erosion event.

Q4 FY26 consolidated financial snapshot

A key detail behind the margin math is the change in cost mix. Materials cost fell to 31.6 percent of revenue from 34.1 percent, while A and P rose to 22.9 percent from 19.6 percent. Staff cost also rose as a percentage of revenue to 12.6 percent from 11.5 percent.

FY26: a flat revenue year, but margins held up and cash stayed strong

FY26 was challenging for similar reasons, mainly seasonality volatility, geopolitical headwinds, and the implementation of GST 2.0 as cited by management. Revenue from operations declined 1 percent year on year to 3,779.5 crore, while EBITDA fell 6 percent to 963.6 crore. Profit after tax declined 3 percent to 775.3 crore.

But the yearly view also shows cost discipline. Gross margins expanded 130 basis points to 69.9 percent. Materials cost as a share of revenue improved to 30.1 percent from 31.4 percent. This improvement was partly offset by higher staff and brand spending: staff costs rose to 12.7 percent from 11.7 percent, and A and P rose to 19.6 percent from 18.2 percent.

The business mix also stayed stable. International business grew 3 percent for FY26 and contributed 18 percent of overall sales for the year. Within international, the FY26 contribution split was 41 percent MENA, 40 percent SAARC and SEA, and 12 percent CIS.

A notable strength remains Emami’s balance sheet position. The company reported net cash of 883 crore as of 31 March 2026. Total equity rose to 2,922.4 crore from 2,693.4 crore a year earlier. Investors also received significant cash returns: interim dividends totaled 10 per share, with a total payout of 436.5 crore. The company stated this represented 51 percent of adjusted profits and 56 percent of reported profit.

Portfolio and channel shift: the long-term story behind the quarter

Emami’s presentation made it clear that the near-term quarterly volatility is being managed alongside a longer-term repositioning of the portfolio and go-to-market model.

First is the shift toward new-age and mainstream offerings. New age and mainstream portfolio contribution to domestic business rose to 21 percent in FY26 from 15 percent in FY23 and 7 percent in FY20. The company stated a five-year CAGR of 27 percent for this mix shift.

Second is the channel transformation. Organised and new age channels contributed about 32 percent of domestic business in FY26, up from 24 percent in FY23 and 12 percent in FY20. The company attributed this to evolving buying behavior and a deliberate reduction in dependence on traditional general trade and wholesale.

Third is the rise of D2C brands within the domestic base. D2C contribution rose to 9 percent in FY26 from 5 percent in FY23 and 0 percent in FY20, with a stated five-year CAGR of 83 percent. Zunducare, The Man Company, and Brillare were cited as the key contributors, with IncNut expected to accelerate growth in FY27.

This three-part shift helps explain why Emami continues to spend through the cycle. Advertising and promotion rose in Q4 despite revenue pressure. That is consistent with a strategy where brand and distribution investments are not seen as discretionary, but as necessary to defend and grow share across faster-growing channels.

Domestic performance: quarter versus year

The table highlights a key point: Q4 was not uniformly weak. Several lines delivered strong growth, and the year-level pressure is heavily concentrated in the summer-led portfolio.

Strategic investments: building optionality in healthy beverages and personalized BPC

Emami used the period around the year-end to deepen its position in segments that can reshape the growth profile.

In Q1 FY27, the company increased its stake in Axiom Ayurveda, making it a subsidiary effective 1 April 2026. The remaining stake is expected to be acquired by June 2026. Management positioned this as an entry into the healthy beverage segment through AloFrut.

The company is also acquiring a majority stake in IncNut, which owns digital-first brands such as Vedix and SkinKraft. This expands Emami’s presence in the personalized beauty and personal care segment, with relevance across India and global markets.

These moves fit with the portfolio data already visible in the presentation. New-age categories and D2C are growing as a share of domestic business, and the company is attempting to accelerate that shift through targeted acquisitions rather than only organic brand extensions.

Management commentary in the presentation reinforced two themes: resilience and discipline. The vice chairman and managing director described the headwinds as temporary and said momentum is expected to improve from the next quarter. The vice chairman and whole-time director emphasized disciplined execution, including gross margin expansion and continued brand investment. He also noted early trends in Q1 FY27, particularly for the summer portfolio, supported by expanded distribution, media investment, and stronger trade activation.

Investor takeaways: what to watch after a disrupted quarter

Emami’s Q4 FY26 numbers were weaker on the surface, but the details point to a business that still has operating control. Gross margins expanded sharply even as the company increased advertising. Core domestic categories grew at double digits outside the summer portfolio. International weakness came largely from a late-quarter disruption tied to shipping and freight routes.

The near-term question is how quickly the summer portfolio normalizes and whether international logistics stabilizes as the West Asia situation evolves. The medium-term question is whether the ongoing channel shift toward organised outlets and quick commerce, and the portfolio shift toward new-age and D2C-led brands, can lift structural growth without sacrificing profitability.

The company enters FY27 with net cash of 883 crore, a stated debt-free balance sheet position, and a track record of returning capital through a 10 per share interim dividend in FY26. At the same time, it is leaning into acquisitions in healthy beverages and personalized BPC. If Q1 FY27 seasonality improves as management suggested, Emami’s story may move from damage control back to portfolio-led growth, with organised channels and digital-first brands doing more of the heavy lifting.